Related Experiment Video
Updated: Jun 28, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
HIV rebounds from latently infected cells, rather than from continuing low-level replication
Beda Joos1, Marek Fischer, Herbert Kuster
1Department of Medicine, Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, CH-8091 Zurich, Switzerland. beda.joos@usz.ch
HIV rebound after combination antiretroviral therapy (cART) interruption stems from reactivated latent cells, not low-level replication. This suggests a sustained evolutionary bottleneck, delaying viral diversity restoration post-treatment.
Area of Science:
- Virology
- Immunology
- Evolutionary Biology
Background:
- Long-term combination antiretroviral therapy (cART) suppresses HIV-1 replication.
- Interruption of cART leads to rapid viral rebound, suggesting persistent reservoirs or reactivation.
Purpose of the Study:
- To investigate the origin and evolution of rebounding HIV during structured treatment interruptions (STI).
- To determine if low-level replication or reactivation of latent cells drives viral rebound.
Main Methods:
- Longitudinal clonal evolutionary studies of HIV env C2-V3-C3 regions.
- Analysis of rebounding plasma viruses in 20 HIV-1 patients during multiple 2-week STIs.
- Comparison of rebounding virus sequences with pretreatment sequences.
Main Results:
- Rebounding virus during STI was homogeneous, indicating mono- or oligoclonal origin.
- No temporal structure found between rebounding virus and pretreatment sequences.
- Distinct viral lineages emerged at different STI cycles, implying stochastic reactivation from latent reservoirs.
- Restoration of pretreatment viral diversity took over 2.5 years, revealing a sustained evolutionary bottleneck.
Conclusions:
- HIV rebound after cART interruption is driven by stochastic reactivation of latent clones, not ongoing low-level replication.
- Punctuated antiretroviral therapy induces a prolonged evolutionary bottleneck, delaying viral diversity recovery.
Related Concept Videos
Size and Structure of Viral Genomes
Retrovirus Life Cycles
Viruses with RNA Genomes
Viral Mutations
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Virion Maturation and Assembly

